NuVasive to Participate in 39th Annual Virtual J.P. Morgan Healthcare Conference
NuVasive, Inc. (NASDAQ: NUVA), a leader in spine technology innovation, announced that CEO J. Christopher Barry will present at the 39th Annual Virtual J.P. Morgan Healthcare Conference on January 13, 2021, at 2:50 p.m. ET. A live webcast will be available on the company's Investor Relations page, with a replay accessible for 30 days after the event. NuVasive focuses on less invasive surgical solutions and aims to enhance patient care, with over $1 billion in net sales and operations in more than 50 countries.
- None.
- None.
SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive Chief Executive Officer, J. Christopher Barry will present at the 39th Annual Virtual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 2:50 p.m. ET/ 11:50 a.m. PT.
A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. A replay of the presentation will remain available on the website for 30 days after the live webcast.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes access, implants and fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With more than
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA® platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvasive-to-participate-in-39th-annual-virtual-jp-morgan-healthcare-conference-301200514.html
SOURCE NuVasive, Inc.
FAQ
When will NuVasive present at the J.P. Morgan Healthcare Conference?
How can I watch the NuVasive presentation live?
What is the main focus of NuVasive's business?
How long will the NuVasive presentation replay be available?
What is NuVasive's net sales figure?
